Erowid.org: Erowid Reference 7927 : Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine 2C-B in mice, after acute administration : Carmo H, de Boer D, Remião F, Carvalho F, dos Reys LA, de Lourdes Bastos M

Erowid References Database

Carmo H, de Boer D, Remião F, Carvalho F, dos Reys LA, de Lourdes Bastos M. “Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine 2C-B in mice, after acute administration”. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Nov 03;811(2):143-52. <a name="ref">Carmo H, de Boer D, Remião F, Carvalho F, dos Reys LA, de Lourdes Bastos M.</a> <a href="/references/7927">"Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine 2C-B in mice, after acute administration"</a> <i>J Chromatogr B Analyt Technol Biomed Life Sci</i>. 2004 Nov 03;811(2):143-52.
Text Abstract (this page) Full Text - English (private) Show Articles by Carmo H de Boer D Remião F Carvalho F dos Reys LA de Lourdes Bastos M Article IDs Erowid RefID: 7927 PubMedID: 15522713 Collections Hofmann Collection MDMA Collection All References	Abstract 4-Bromo-2,5-dimethoxyphenethylamine 2C-B is a psychoactive drug of abuse often sold under the general street name 'Ecstasy'. Recent reports on the abuse of 2C-B and analogues denote the lack of knowledge on this drug metabolism. In the present study, we investigated the metabolic profile of 2C-B in the mouse and found unchanged 2C-B and several metabolites, which could be identified by GC/MS in the mice urine. The identification of 2C-B metabolites may give important clues for the biological and toxicological effects of this drug of abuse and provides new important data for forensic analysis on samples taken from 2C-B abusers.
Comments and Responses to this Article #
Submit Comment

[ Cite HTML ]